Cargando…
Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection
Patient outcomes during infection are due to a complex interplay between the quality of medical care, host immunity factors, and the infecting pathogen’s characteristics. To probe the influence of pathogen genotype on human survival, immune response, and other parameters of disease, we examined Cryp...
Autores principales: | Gerstein, Aleeza C., Jackson, Katrina M., McDonald, Tami R., Wang, Yina, Lueck, Benjamin D., Bohjanen, Sara, Smith, Kyle D., Akampurira, Andrew, Meya, David B., Xue, Chaoyang, Boulware, David R., Nielsen, Kirsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635531/ https://www.ncbi.nlm.nih.gov/pubmed/31311883 http://dx.doi.org/10.1128/mBio.01440-19 |
Ejemplares similares
-
ATI-2307 Exhibits Equivalent Antifungal Activity in Cryptococcus neoformans Clinical Isolates With High and Low Fluconazole IC(50)
por: Gerlach, Elliot S., et al.
Publicado: (2021) -
The Cryptococcus neoformans Transcriptome at the Site of Human Meningitis
por: Chen, Yuan, et al.
Publicado: (2014) -
829. 5-Flucytosine Longitudinal Antifungal Susceptibility Testing of Cryptococcus neoformans: A Sub-study of the EnACT Trial Testing Oral Amphotericin
por: McHale, Thomas, et al.
Publicado: (2023) -
The interplay of phenotype and genotype in Cryptococcus neoformans disease
por: Altamirano, Sophie, et al.
Publicado: (2020) -
Importance of Clinical Isolates in Cryptococcus neoformans Research
por: Jackson, Katrina M., et al.
Publicado: (2023)